Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03351738 · ClinicalTrials.gov registry record · Phase 2
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease
A Phase 2 study, sponsored by MedImmune.
- Completed
- Registry status
- Phase 2
- Development phase
- 133
- Enrollment target
NCT03351738 is a Phase 2 study that has completed, run by MedImmune. The registered enrollment target is 133 participants.
The verdict
NCT03351738, a Phase 2 study, has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 133 participants
- Enrollment target
Study Summary
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease.
Interventions
- DRUG Placebo
- DRUG MEDI5884
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2017-12-13 |
| Est. Completion | 2018-11-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03351738
The ClinicalTrials.gov registry entry for NCT03351738 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 133 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03351738 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03351738 about?
NCT03351738 is a clinical study titled "A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease". A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease.
What is the current status of trial NCT03351738?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 133 participants. The study started on 2017-12-13. Estimated completion is 2018-11-09.
What interventions are being tested in trial NCT03351738?
The interventions under investigation include: Placebo (DRUG), MEDI5884 (DRUG).
Who is sponsoring clinical trial NCT03351738?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.